Nanocarrier-Integrated Topical Dosage Forms for Biofilm-Infected Wounds: Balancing Wound Retention, Biofilm Matrix Penetration, and Translational Feasibility
International Journal of Nanomedicine · 2026
DOI: 10.2147/ijn.s643386 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Nanomedicine, 2026. Verfasst von Sri Agung Fitri Kusuma. Beteiligte Einrichtung: Department of Pharmaceutical Biology, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, West Java, Indonesia. Hauptthemen laut MEDLINE: Biofilms, Wound Infection, Drug Carriers, Anti-Infective Agents. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Biology, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, West Java, Indonesia.
ORCID-Profile: Sri Agung Fitri Kusuma
Zitieren
APA
Kusuma, S. A. F. (2026). Nanocarrier-Integrated Topical Dosage Forms for Biofilm-Infected Wounds: Balancing Wound Retention, Biofilm Matrix Penetration, and Translational Feasibility. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s643386
Vancouver
Kusuma SAF. Nanocarrier-Integrated Topical Dosage Forms for Biofilm-Infected Wounds: Balancing Wound Retention, Biofilm Matrix Penetration, and Translational Feasibility. International Journal of Nanomedicine. 2026. doi:10.2147/ijn.s643386
BibTeX
@article{Kusuma2026,
author = {Kusuma, Sri Agung Fitri},
title = {Nanocarrier-Integrated Topical Dosage Forms for Biofilm-Infected Wounds: Balancing Wound Retention, Biofilm Matrix Penetration, and Translational Feasibility},
journal = {International Journal of Nanomedicine},
year = {2026},
doi = {10.2147/ijn.s643386}
}
EUVIMED